Moreover, an effective small‐molecule inhibitor of NSUN2 has been indentified in diminishing the enzymatic function and the expression of downstream targets, offering a novel and promising therapeutic option in the realm of cancer immunotherapy for CRC. Here, NSUN2 is linked to colorectal carcinoma.